These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 5871676)
1. The use of lipolytic drugs. Geill T Gerontol Clin (Basel); 1965; 7(6):321-9. PubMed ID: 5871676 [No Abstract] [Full Text] [Related]
2. [Differentiation and drug therapy of lipemias]. Schettler G Dtsch Med J; 1968 Apr; 19(8):250-8. PubMed ID: 5728720 [No Abstract] [Full Text] [Related]
3. Treatment of hyperlipidemic states. Strisower EH; Adamson G; Strisower B Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683 [No Abstract] [Full Text] [Related]
4. [Medical treatment of hyperlipemia. Indications and modern preparations]. Frey H Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311 [No Abstract] [Full Text] [Related]
5. Measures to reduce the serum lipid levels in coronary heart disease. Connor WE Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837 [No Abstract] [Full Text] [Related]
6. Control of biochemical precursors of coronary heart disease. Ostrander LD Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631 [No Abstract] [Full Text] [Related]
9. Management of the hyperlipidemic patient. Berkowitz D Med Clin North Am; 1973 Jul; 57(4):881-92. PubMed ID: 4576152 [No Abstract] [Full Text] [Related]
10. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics]. Martinelli M; Albini U; Villecco A Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650 [No Abstract] [Full Text] [Related]
11. The chemotherapy of hypercholesterolaemia. Heffernan A; Hickey N; Mulcahy R; Fitzgerald O Acta Cardiol; 1969; 24(1):47-55. PubMed ID: 5310563 [No Abstract] [Full Text] [Related]
13. New drugs for the treatment of hypercholesterolemia. Hamlin JT Va Med Mon (1918); 1969 Jan; 96(1):11-2. PubMed ID: 5763103 [No Abstract] [Full Text] [Related]
14. [Therapy of primary hyperlipemia]. Schneider J; Kaffarnik H Dtsch Med Wochenschr; 1971 May; 96(19):831-2. PubMed ID: 5574353 [No Abstract] [Full Text] [Related]
15. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia]. De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027 [No Abstract] [Full Text] [Related]
16. Drug therapy of hyperlipoproteinemia. Levy RI JAMA; 1976 May; 235(21):2334-6. PubMed ID: 946632 [No Abstract] [Full Text] [Related]
17. The use of pharmacologic agents in atherosclerosis therapy. Kritchevsky D Ann N Y Acad Sci; 1968 Nov; 149(2):1058-68. PubMed ID: 4890515 [No Abstract] [Full Text] [Related]
18. [Therapy of primary hyperlipemias]. Schlierf G; Kahlke W Dtsch Med Wochenschr; 1969 Feb; 94(7):329-32. PubMed ID: 5762992 [No Abstract] [Full Text] [Related]
19. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood]. Cloarec M; Cottet J; Etienne J; Loeper J Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602 [No Abstract] [Full Text] [Related]
20. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid. Nordoy A; Gjone E Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813 [No Abstract] [Full Text] [Related] [Next] [New Search]